David L. Wachter - Concepedia

Author

David L. Wachter

Also Known As

A Hartmann, D L Wachter, D. L. Wachter, D.L. Wachter, David L Wachter, David L. Wachter, David Lukas Wachter, David Wachter

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Universitätsklinikum Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg Comprehensive Cancer Center Erlangen University of California, Los Angeles Heidelberg University

About

David L. Wachter is an author at Universitätsklinikum Erlangen specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	1K
2	Health Sciences	4	4	330
3	Engineering	2	2	139
4	Public Health	2	2	35
5	Natural Sciences	1	1	10

David L. Wachter

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies Xiaohong R. Yang, Jenny Chang‐Claude, Ellen L. Goode, JNCI Journal of the National Cancer Institute	2010	711
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli, JAMA Oncology	2017	388
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment Peter A. Fasching, Katharina Heusinger, Lothar Haeberle, BMC Cancer	2011	322
DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer Andrew E. Teschendorff, Yang Gao, Allison Jones, Nature Communications	2016	275
SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma Abbas Agaimy, Michael Koch, Michael Lell, The American Journal of Surgical Pathology Surgical OncologyPathologyTumor BiologyOral CancerCarcinoma	2014	160
On a dark-field signal generated by micrometer-sized calcifications in phase-contrast mammography Thilo Michel, Jens Rieger, G. Anton, Physics in Medicine and Biology EngineeringOncologic ImagingMicroscopyPolycapillary OpticsX-ray Imaging	2013	128
Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant Johanna Strehl, David L. Wachter, Jutta Fiedler, Annals of Diagnostic Pathology Endometrioid AdenocarcinomaTumor BiologyRhabdoid VariantPathologyGynecology	2015	121
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer Michael P. Lux, Claudia Rauh, Alexander Hein, BMC Cancer	2018	83
Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets Pamela L. Strissel, Matthias Ruebner, Falk C. Thiel, Oncotarget	2012	81
Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes Matthias Ruebner, Pamela L. Strissel, Manuela Langbein, Journal of Molecular Medicine Maternal ImmunizationImpaired Cell FusionDevelopmental BiologyPlacental DevelopmentMedicine	2010	78

Page 1